Antimicrobial Agents Practice Questions

Q: What is the role of ethambutol in the Revised National Tuberculosis Control Programme (RNTCP) regimen?

Bacteriostatic and detrimental to fast multiplying bacilli. ### Explanation **1. Why the Correct Answer is Right:** Ethambutol is a **bacteriostatic** antitubercular drug. Its primary mechanism of action involves the inhibition of the enzyme **arabinosyl transferase**, which is essential for the synthesis of arabinogalactan (a critical component of the mycobacterial cell wall). Since cell wall synthesis occurs most actively during cell division, ethambutol is most effective against **fast-multiplying bacilli** (extracellular bacteria). By inhibiting wall synthesis, it prevents the multiplication of the bacteria rather than killing them directly. **2. Why the Other Options are Wrong:** * **Options A & B (Bactericidal):** Ethambutol is the only primary antitubercular drug that is bacteriostatic at standard therapeutic doses. Drugs like Isoniazid, Rifampicin, and Pyrazinamide are bactericidal. * **Options B & D (Dormant/Slow multiplying):** Ethambutol has no significant activity against dormant (latent) or slow-multiplying (intracellular) bacilli. **Pyrazinamide** is the drug of choice for acidic environments (intracellular/slow-multiplying), while **Rifampicin** is highly effective against spurters (semidormant bacilli). **3. NEET-PG High-Yield Clinical Pearls:** * **Visual Side Effects:** The most characteristic side effect is **Retrobulbar Neuritis**, leading to decreased visual acuity, central scotoma, and **red-green color blindness**. It is generally dose-dependent and reversible. * **Contraindication:** It should be avoided in children below 6 years of age because they cannot reliably report changes in visual acuity or color perception. * **Uric Acid:** Like Pyrazinamide, Ethambutol can decrease the excretion of uric acid, potentially leading to **hyperuricemia**. * **Role in RNTCP:** Its primary role in the Intensive Phase (2HRZE) is to prevent the emergence of resistance to more potent drugs like Isoniazid and Rifampicin.

Q: A person on anti-tubercular drugs complained of deafness and tinnitus in one ear. Which drug is most likely implicated?

Streptomycin. **Explanation:** The correct answer is **Streptomycin**. **1. Why Streptomycin is correct:** Streptomycin is an **Aminoglycoside** antibiotic used as a first-line injectable drug in the treatment of Tuberculosis. The hallmark toxicity of aminoglycosides is **ototoxicity**, which occurs due to the destruction of sensory hair cells in the inner ear. Streptomycin specifically targets the **vestibulocochlear nerve (Cranial Nerve VIII)**. While it is more vestibulotoxic (causing vertigo and ataxia), it also causes permanent cochlear damage, leading to **tinnitus and sensorineural hearing loss (deafness)**. **2. Why the other options are incorrect:** * **Isoniazid (INH):** The most characteristic side effect is **peripheral neuropathy** (due to Vitamin B6 deficiency) and hepatotoxicity. It does not affect hearing. * **Ethambutol:** The classic adverse effect is **retrobulbar neuritis**, which manifests as decreased visual acuity and **red-green color blindness**. It is not ototoxic. * **Rifampicin:** Known for causing **orange-colored discoloration** of body fluids (urine, sweat, tears) and hepatotoxicity. It does not cause deafness. **Clinical Pearls for NEET-PG:** * **Ototoxicity:** Streptomycin is more vestibulotoxic, whereas Amikacin and Kanamycin are more cochleotoxic. * **Pregnancy:** Streptomycin is **contraindicated in pregnancy** because it can cross the placenta and cause congenital deafness in the fetus. * **Renal Monitoring:** Since aminoglycosides are excreted unchanged by the kidneys, dose adjustment is required in renal failure to prevent both ototoxicity and nephrotoxicity. * **Mnemonic for Ethambutol:** **E**thambutol for **E**ye (Optic neuritis).

Q: Which of the following is NOT a potential adverse effect of fluoroquinolones?

Blindness. **Explanation:** Fluoroquinolones (e.g., Ciprofloxacin, Levofloxacin, Moxifloxacin) are broad-spectrum bactericidal antibiotics that inhibit DNA gyrase and Topoisomerase IV. While they have a wide range of side effects, **blindness** is not a recognized adverse effect of this drug class. * **Why Option D is correct:** Fluoroquinolones are associated with various ocular side effects like blurred vision or, rarely, retinal detachment, but they do **not** cause blindness. In contrast, drugs like Ethambutol (optic neuritis) or Quinine are classic causes of toxic amblyopia/blindness. * **Why other options are incorrect:** * **A. Abdominal discomfort:** GI upset (nausea, vomiting, diarrhea) is the most common side effect of fluoroquinolones. * **B. Dysglycemia:** Fluoroquinolones (especially Gatifloxacin, which was withdrawn for this reason) can cause both hypoglycemia and hyperglycemia by affecting pancreatic K+ channels. * **C. QT prolongation:** Moxifloxacin and Sparfloxacin are notorious for prolonging the QT interval, increasing the risk of Torsades de Pointes. **High-Yield Clinical Pearls for NEET-PG:** * **Musculoskeletal:** They cause **tendon rupture** (Achilles tendon) and arthropathy; thus, they are generally avoided in children and pregnancy. * **CNS:** They can lower the seizure threshold (GABA antagonism). * **Contraindication:** Avoid in **Myasthenia Gravis** as they can exacerbate muscle weakness. * **Phototoxicity:** Patients should be advised to avoid excessive sunlight.

Q: Tetracycline in children causes what?

Discolored teeth. **Explanation:** The correct answer is **Discolored teeth (Option C)**. **Mechanism of Action:** Tetracyclines are broad-spectrum bacteriostatic antibiotics. They have a high affinity for calcium ions and form a stable **tetracycline-calcium orthophosphate complex**. When administered during the period of tooth development (calcification), this complex is permanently deposited in the dentin and enamel. Under exposure to light, this complex undergoes oxidation, leading to a characteristic **yellowish-brown or gray-brown permanent discoloration** and potential enamel hypoplasia. **Analysis of Incorrect Options:** * **A. Calcification:** Tetracyclines do not cause calcification; rather, they interfere with the process and deposit into tissues that are *already* undergoing calcification (teeth and bones). * **B. Missing teeth (Anodontia):** Tetracyclines do not affect the number of teeth or the formation of tooth buds; they only affect the structure and color of the developing tooth. * **D. Peg teeth:** This refers to a morphological abnormality (like Hutchinson’s teeth in Congenital Syphilis). Tetracyclines affect the color and integrity of the enamel, not the fundamental shape of the tooth. **High-Yield NEET-PG Pearls:** * **Contraindications:** Tetracyclines are strictly contraindicated in **pregnant women** (after the 4th month) and **children below 8 years of age**. * **Bone Growth:** They can also deposit in growing bones, causing a temporary suppression of fibular growth. * **Fanconi Syndrome:** Use of **outdated/expired tetracyclines** leads to Fanconi-like syndrome (renal tubular acidosis) due to degradation products like epianhydrotetracycline. * **Doxycycline:** It is the safest tetracycline in renal failure (excreted via bile) and has a lower affinity for calcium compared to older tetracyclines, though the clinical precaution remains the same.

Q: A female patient treated with antibiotics for chlamydia-induced UTI presents with itching/pruritus, vaginal discharge, and burning micturition. Which drug should be given?

Azithromycin. ### **Explanation** **Correct Option: B. Azithromycin** The clinical scenario describes a patient with a **Chlamydial urinary tract infection (UTI)/Urethritis**. *Chlamydia trachomatis* is an obligate intracellular pathogen. **Azithromycin**, a macrolide, is the drug of choice because it achieves high intracellular concentrations and has a long half-life, allowing for a **single-dose (1g)** curative regimen. This ensures high patient compliance compared to multi-day courses. **Analysis of Incorrect Options:** * **A. Ceftriaxone:** This is a third-generation cephalosporin used primarily for *Neisseria gonorrhoeae*. While Chlamydia and Gonorrhea often co-infect, Ceftriaxone is ineffective against Chlamydia because the organism lacks a typical peptidoglycan cell wall (the target of beta-lactams). * **C. Moxifloxacin:** While some fluoroquinolones (like Ofloxacin or Levofloxacin) can treat Chlamydia, they are second-line agents. Moxifloxacin is generally reserved for respiratory infections or resistant Pelvic Inflammatory Disease (PID) and is not the primary choice for uncomplicated Chlamydial UTI. * **D. Amphotericin B:** This is a potent antifungal used for systemic fungal infections (e.g., Mucormycosis). It has no activity against bacterial pathogens like Chlamydia. **NEET-PG High-Yield Pearls:** * **DOC for Chlamydia:** Azithromycin (1g stat) or Doxycycline (100mg BID for 7 days). * **Pregnancy:** Azithromycin is the preferred agent for Chlamydia in pregnant women (Doxycycline is contraindicated due to fetal bone/teeth effects). * **Syndromic Management (Green Kit):** Used for vaginal discharge; contains Fluconazole (for Candidiasis) and Azithromycin (for Chlamydia). * **Reiter’s Syndrome:** A classic triad of "Can't see, can't pee, can't climb a tree" (Uveitis, Urethritis, Arthritis) often triggered by a Chlamydia infection.

Q: Which of the following is a fifth-generation cephalosporin?

Ceftaroline. **Explanation:** **Ceftaroline** is the correct answer as it is a member of the **fifth-generation cephalosporins**. The defining clinical characteristic of this generation is its unique ability to bind to **PBP-2a**, an altered penicillin-binding protein that confers resistance in Staphylococci. This makes fifth-generation agents the only cephalosporins effective against **Methicillin-resistant *Staphylococcus aureus* (MRSA)**. **Analysis of Incorrect Options:** * **Cefepime (Option A):** This is a **fourth-generation** cephalosporin. It is a "zwitterion" that can rapidly penetrate the outer membrane of Gram-negative bacteria. It is highly effective against *Pseudomonas aeruginosa* but lacks activity against MRSA. * **Cefpirome (Option C):** Also a **fourth-generation** cephalosporin, similar in spectrum to Cefepime, primarily used for life-threatening nosocomial infections. * **Cefprozil (Option D):** This is a **second-generation** oral cephalosporin used mainly for respiratory tract infections and skin/soft tissue infections. **High-Yield Clinical Pearls for NEET-PG:** * **Fifth-Generation Agents:** Include **Ceftaroline** and **Ceftobiprole**. * **MRSA Coverage:** Remember the mnemonic: "Ceftaroline covers the 'Staph' that others can't." * **VRSA & VISA:** Ceftaroline also shows activity against Vancomycin-resistant and Vancomycin-intermediate *S. aureus*. * **LAME Mnemonic:** Cephalosporins generally do **NOT** cover **L**isteria, **A**typicals (Mycoplasma/Chlamydia), **M**RSA (except 5th gen), and **E**nterococci (except Ceftaroline/Ceftobiprole which have some Enterococcal activity). * **Excretion:** Most cephalosporins are renally excreted; **Ceftriaxone** is a notable exception (biliary excretion), requiring no dose adjustment in renal failure.

Q: Which of the following drugs acts by inhibiting cell wall synthesis?

Cephalosporins. **Explanation:** The correct answer is **B. Cephalosporins**. **Mechanism of Action:** Cephalosporins are **Beta-lactam antibiotics** that act by inhibiting bacterial cell wall synthesis. They bind to and inhibit **Penicillin-Binding Proteins (PBPs)**, which are enzymes (transpeptidases) responsible for cross-linking peptidoglycan chains. This disruption leads to a weakened cell wall, resulting in osmotic lysis and bacterial death (bactericidal action). **Analysis of Incorrect Options:** * **A. Erythromycin:** This is a Macrolide that inhibits **protein synthesis** by binding to the **50S ribosomal subunit**. * **C. Chloramphenicol:** This drug also inhibits **protein synthesis** by binding to the **50S ribosomal subunit** and preventing peptide bond formation. * **D. Sulfonamides:** These are antimetabolites that inhibit **folic acid synthesis** by competitively inhibiting the enzyme dihydropteroate synthase. **High-Yield Clinical Pearls for NEET-PG:** * **Cell Wall Inhibitors:** Remember the mnemonic **"V-P-C-B"** (Vancomycin, Penicillins, Cephalosporins, Bacitracin/Cycloserine). * **Bactericidal vs. Bacteriostatic:** Most cell wall inhibitors (like Cephalosporins) are **bactericidal**, whereas most protein synthesis inhibitors (except Aminoglycosides) are **bacteriostatic**. * **Cross-Reactivity:** Patients with a history of severe immediate hypersensitivity (anaphylaxis) to Penicillins should avoid Cephalosporins due to a 5-10% risk of cross-reactivity. * **Resistance:** The most common mechanism of resistance against Cephalosporins is the production of **Beta-lactamases**.

Q: What is the mechanism of action of Oseltamivir and Zanamivir?

Neuraminidase inhibition. **Mechanism of Action: Neuraminidase Inhibitors** **Correct Answer: D. Neuraminidase inhibition** Oseltamivir and Zanamivir are structural analogs of sialic acid. Their primary mechanism involves the competitive inhibition of **Neuraminidase (NA)**, an enzyme found on the surface of Influenza A and B viruses. * **The Concept:** During the viral life cycle, new virions bud from the host cell membrane but remain attached via hemagglutinin to sialic acid receptors. Neuraminidase cleaves these receptors, allowing the release of progeny virions. By inhibiting this enzyme, Oseltamivir and Zanamivir cause the newly formed viruses to clump together and remain stuck to the host cell, thereby preventing the infection of new cells. **Why other options are incorrect:** * **A & B (DNA polymerase/mRNA inhibition):** These are mechanisms typical of anti-herpetic drugs (e.g., Acyclovir) or certain RNA polymerase inhibitors (e.g., Ribavirin). Influenza is an RNA virus, and these drugs do not target its genetic replication directly. * **C (Blocking viral uncoating):** This is the mechanism of **Amantadine and Rimantadine**, which inhibit the **M2 ion channel** [3]. These drugs are now largely obsolete due to widespread resistance. **High-Yield Clinical Pearls for NEET-PG:** * **Timing:** These drugs are most effective when started within **48 hours** of symptom onset [1], [2]. * **Routes:** Oseltamivir is **oral** (prodrug) [2], while Zanamivir is **inhaled** (contraindicated in asthma/COPD due to risk of bronchospasm). * **Peramivir:** An intravenous neuraminidase inhibitor used for acute uncomplicated influenza. * **Baloxavir Marboxil:** A newer agent that inhibits **cap-dependent endonuclease**, blocking viral mRNA synthesis (a frequent "next-step" question).

Q: Which of the following antimicrobial agents inhibits protein synthesis by blocking translocation?

Macrolides. **Explanation:** Protein synthesis inhibitors are a high-yield topic in NEET-PG. To understand the mechanism, one must identify the specific step of translation being targeted. **1. Why Macrolides are correct:** Macrolides (e.g., Erythromycin, Azithromycin) bind to the **50S ribosomal subunit**. Their primary mechanism is inhibiting the **translocation** step. During translocation, the peptidyl-tRNA moves from the A-site (Aminoacyl) to the P-site (Peptidyl) on the ribosome. Macrolides block this movement, effectively "freezing" the protein chain elongation. **2. Analysis of Incorrect Options:** * **Aminoglycosides (A):** These bind to the **30S subunit**. Their primary action is causing **mRNA misreading** and inhibiting the initiation complex formation, rather than blocking translocation. * **Tetracyclines (B):** These bind to the **30S subunit** and block the **attachment of aminoacyl-tRNA to the A-site**. They prevent the "entry" of new amino acids. * **Chloramphenicol (D):** This binds to the **50S subunit** but specifically inhibits **peptidyl transferase**, the enzyme responsible for forming peptide bonds between amino acids. **3. Clinical Pearls for NEET-PG:** * **Mnemonic for 50S inhibitors:** "**C**ell **C**an't **M**ake **L**ong **P**eptides" (**C**hloramphenicol, **C**lindamycin, **M**acrolides, **L**inezolid, **P**leuromutilins). * **Resistance Mechanism:** The most common resistance to Macrolides is via **methylation of the 23S rRNA** (target site modification by *erm* genes). * **Prokinetic effect:** Erythromycin acts as a motilin receptor agonist, used clinically in gastroparesis.

Question 1

What is the role of ethambutol in the Revised National Tuberculosis Control Programme (RNTCP) regimen?

Accepted Answer

Bacteriostatic and detrimental to fast multiplying bacilli

Answer

Bactericidal and detrimental to semidormant bacilli

Answer

Bactericidal and detrimental to dormant bacilli

Answer

Bacteriostatic and detrimental to slow multiplying bacilli

Question 2

A person on anti-tubercular drugs complained of deafness and tinnitus in one ear. Which drug is most likely implicated?

Accepted Answer

Streptomycin

Answer

Isoniazid

Answer

Ethambutol

Answer

Rifampicin

Question 3

Efavirenz limits HIV infection by:

Accepted Answer

Serving as an allosteric inhibitor of HIV reverse transcriptase

Answer

Binding to the active site of HIV reverse transcriptase

Answer

Impairing the binding of HIV virion to CD4 receptors on T-cells

Answer

Inhibiting the HIV protease

Question 4

Which of the following is NOT a potential adverse effect of fluoroquinolones?

Accepted Answer

Blindness

Answer

Abdominal discomfort

Answer

Dysglycemia

Answer

QT prolongation

Question 5

Tetracycline in children causes what?

Accepted Answer

Discolored teeth

Answer

Calcification

Answer

Missing teeth

Answer

Peg teeth

Question 6

A female patient treated with antibiotics for chlamydia-induced UTI presents with itching/pruritus, vaginal discharge, and burning micturition. Which drug should be given?

Accepted Answer

Azithromycin

Answer

Ceftriaxone

Answer

Moxifloxacin

Answer

Amphotericin B

Question 7

Which of the following is a fifth-generation cephalosporin?

Accepted Answer

Ceftaroline

Answer

Cefepime

Answer

Cefpirome

Answer

Cefprozil

Question 8

Which of the following drugs acts by inhibiting cell wall synthesis?

Accepted Answer

Cephalosporins

Answer

Erythromycin

Answer

Chloramphenicol

Answer

Sulfonamides

Question 9

What is the mechanism of action of Oseltamivir and Zanamivir?

Accepted Answer

Neuraminidase inhibition

Answer

DNA polymerase inhibition

Answer

Inhibition of viral mRNA

Answer

Blocking viral uncoating

Question 10

Which of the following antimicrobial agents inhibits protein synthesis by blocking translocation?

Accepted Answer

Macrolides

Answer

Aminoglycosides

Answer

Tetracyclines

Answer

Chloramphenicol

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?